சிகிச்சை காட்சி பெட்டி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.
Eyevensys Named to French Tech 120 Program
February 15, 2021 GMT
PARIS & CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 15, 2021
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been accepted into the French Tech 120 program for 2021.
This government-backed program, run by La French Tech, offers support for 120 French startups considered late-stage and in a hypergrowth phase. Participating companies benefit from a variety of initiatives designed to support the needs of companies in this stage, such as unlimited access to government, public and ministry services, as well as tailored services from partner agencies. Participants will also benefit from collaboration with the French Tech 120 community, and a needs analysis that will help shape future regulations. ....

United Kingdom , France General , United States , Francine Behar Cohen , Pureos Bioventures , Patricia Zilliox , Marion Janic , Global Health Sciences Fund , Inserm Transfert Initiative , European Medicines Agency , Innobio Fund , Boehringer Ingelheim Venture Fund , French Tech , Electrotransfection System , Chief Innovation Officer , Therapy Showcase , Retinitis Pigmentosa , Electro Study , Global Health Sciences , Media Relations Contact , Business Wire , Products And Services , Western Europe , Product Testing , Diagnosis And Treatment , Health Care Industry ,